Inventor · disambiguated record
Raj K. Raheja
Also filed as: RAHEJA RAJ · RAHEJA RAJ K · RAHEJA RAJ KUMAR
30 granted patents·12 pending applications·147 citations·filing 2005–2023
96Inventor score
Top patents by PatentIndex Score
42 records- 0197US9512124B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Dec 6, 2016·32 cites·60 claims
- 0297US9499514B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2015·Granted Nov 22, 2016·28 cites·29 claims
- 0396US9737541B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Aug 22, 2017·12 cites·52 claims
- 0494US9808451B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2016·Granted Nov 7, 2017·12 cites·19 claims
- 0592US9968596B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2017·Granted May 15, 2018·8 cites·26 claims
- 0690US11241423B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2019·Granted Feb 8, 2022·2 cites·6 claims
- 0790US10227325B2Antiproliferative compounds, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Granted Mar 12, 2019·6 cites·18 claims
- 0889US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0989US9556126B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2014·Granted Jan 31, 2017·10 cites·32 claims
- 1088US10398700B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 1188US9938254B2Antiproliferative compounds, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted Apr 10, 2018·5 cites·33 claims
- 1287US10149849B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Dec 11, 2018·2 cites·3 claims
- 1386US9156798B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Oct 13, 2015·5 cites·30 claims
- 1485US10940152B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2020·Granted Mar 9, 2021·1 cites·27 claims
- 1584US10646493B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 1684US2023158035A1Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2023·Application pending·0 cites
- 1783US9428509B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted Aug 30, 2016·6 cites·32 claims
- 1883US9346812B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2014·Granted May 24, 2016·6 cites·30 claims
- 1979US9783505B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Oct 10, 2017·2 cites·29 claims
- 2079US2022387413A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 2178US10618883B2Antiproliferative compounds, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2019·Granted Apr 14, 2020·1 cites·15 claims
- 2278US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 2375US11590139B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2021·Granted Feb 28, 2023·0 cites·52 claims
- 2469US11365184B2Antiproliferative compounds, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2020·Granted Jun 21, 2022·0 cites·12 claims
- 2564US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 2664US2018221361A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2018·Application pending·0 cites
- 2759US7799823B2Androgen modulatorsWARNER LAMBERT CO·Filed 2006·Granted Sep 21, 2010·0 cites·10 claims
- 2858US11306399B2Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2020·Granted Apr 19, 2022·0 cites·18 claims
- 2955US7470715B2Estrogen modulatorsPFIZER·Filed 2006·Granted Dec 30, 2008·0 cites·5 claims
- 3055US2009131397A1Estrogen modulatorsPFIZER·Filed 2008·Application pending·0 cites
- 3153US9795607B2Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARMACEUTICAL LLC·Filed 2016·Granted Oct 24, 2017·0 cites·33 claims
- 3252US7674819B2Androgen modulatorsWARNER LAMBERT CO·Filed 2006·Granted Mar 9, 2010·0 cites·16 claims
- 3348US11306111B2Organophosphate derivativesJANUARY THERAPEUTICS INC·Filed 2018·Granted Apr 19, 2022·0 cites·19 claims
- 3443US2023099727A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3542US2021299273A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3641US12492177B2RAR-α compounds for inflammatory disease and male contraceptionORPHAGEN PHARMACEUTICALS INC·Filed 2020·Granted Dec 9, 2025·0 cites·18 claims
- 3740US2009105349A1Androgen modulatorsWARNER LAMBERT CO·Filed 2005·Application pending·0 cites
- 3840US2009170886A1Androgen modulatorsPFIZER·Filed 2006·Application pending·0 cites
- 3940US2021007999A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4035US2012022058A14,5-dihydro-1h-pyrazole compounds and their pharmaceutical usesARHANCET GRACIELA BARBIERI·Filed 2010·Application pending·0 cites
- 4134US2021038628A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4234US2021008076A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raj K. Raheja files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →